Introduction
Adenoviral vectors are commonly used as gene delivery vehicles in different gene therapy approaches. 1 Adenoviruses enter cells by receptor-mediated endocytosis which is initiated by the interaction of the fiber protein with a cell surface receptor called the Coxsackievirus group B, adenovirus receptor (CVADR, formerly CAR). Adenovirus serotypes of subgroups A, C, D, E and F all use CVADR as a cellular fiber receptor for attachment to the cell surface. 2 Its cellular function, other than as a virus receptor, remains unknown.
The CVADR mRNA expression is extremely variable between different tissues such as liver, heart, lung and prostate, whereas the ␣ v integrins are more homogenously distributed among different organs. 3, 4 CVADR is broadly expressed during embryonic development in the central and peripheral nervous systems and in several types of epithelial cells. In adults, the expression is more restricted, but remains high mainly in epithelial cells. 5 The adenovirus particle is not surrounded by a lipid envelope and its penetration into the cytoplasm does not depend on membrane fusion events. Instead, disruption of the endosome is believed to permit entry. The penton base protein contains the sequence RGD (arg-gly-asp) (14/24) , whereas integrin ␣ v ␤ 3 was less frequently seen (3/20 6 Wickham et al 7 showed as early as 1993 that these integrins promote viral infection since antibodies against these receptors or soluble pentone base could participate in blocking of infection without affecting attachment of the virus to the cell surface. In a later study, they showed that both integrins ␣ v ␤ 3 and ␣ v ␤ 5 mediate adenovirus binding and internalization, but integrin ␣ v ␤ 5 preferentially promotes virus-induced cell membrane permeabilization and gene delivery as well. 8 It has recently been shown that heparan-sulfate glycoaminoglycans (HS-GAGs) are involved in the binding of adenovirus type 2 and 5. 9 This binding is not essential for adenovirus infection since HS-GAG-negative cells could be transduced and reversibly blocking of HS-GAG only partially inhibited transduction. In contrast, addition of RmcB, a monoclonal antibody against CVADR, completely blocked transduction. 9, 10 There are several other structures that could influence adenoviral transduction of the bladder. A thin layer called bladder surface mucin or mucin-GAG coat covers the normal epithelium. This mucin is reported to represent an antibacterial defense mechanism and could therefore inhibit adenoviral attachment. 11 Ethanol pre-treatment of rat bladders has been shown to enhance the transduction rate possibly due to removal of the mucin layer. 12 It has also been suggested that major histocompatibility complex (MHC) class I could act as a receptor for adenovirus infection. 6 However, in a study by McDonalds et al, 13 no correlation was seen between binding of recombinant fiber knobs and MHC-I expression on several tumor cell lines.
The expression of CVADR varies among human urinary bladder cancer cell lines. 13, 14 In this study we investigated not only cell lines, but actual tumor biopsies from 27 patients for the expression of both CVADR and the integrins ␣ v ␤ 3 and ␣ v ␤ 5 . We further studied the feasibility to transduce human bladder cancer cells with an adenoviral vector containing the gene for the immunostimulatory protein CD154. This particular vector was successfully used in animal studies aiming to develop an immunogene therapy for bladder cancer. 15 The present results indicate that adenoviruses are promising tools for transferring genes into human bladder cancer cells.
Results
Human bladder cancer cell lines and biopsies are broadly positive for CVADR All 27 biopsies representing various tumor stages were positive for CVADR as shown by immunohistochemistry ( Table 1 and Figure 1 ). Most superficial tumors (11/13) were broadly CVADR positive (>80-100%), while onethird of the invasive tumors (5/14) only showed small (Ͻ20%) weakly positive areas within the tumor. Tumor cells close to blood vessels had a higher expression of CVADR. The vessels themselves were, however, negative Table 1 Expression of adenoviral attachment and internalization receptors in human bladder cancer biopsies
a Twenty-seven human urinary bladder cancer biopsies of different stages (Ta, superficial; T1-T2, invasive) and grades were stained for the adenovirus attachment receptor CVADR and the membrane permeabilization and internalization receptors integrin for CVADR expression. All five human bladder cancer cell lines also stained positively for CVADR (Table 2) . T24 was only weakly positive. The CVADR expression on J82 and T24 was not changed if the tumor cell lines were cultured at high or low density (data not shown). As a control for the staining method, 293 cells were positive controls and CHO cells were used as negative controls for CVADR expression. The cell lines were also analyzed for CVADR mRNA expression by RT-PCR. This method confirmed the immunohistochemistry data ( Figure 2 ). Figure 1) . Interestingly, the vessels in the tumor areas were highly positive for both integrins. Integrin ␣ v ␤ 3 has been associated with angiogenesis, which is a prerequisite for tumor growth. 16 All five investigated cell lines were positive for integrin ␣ v ␤ 5 , but only some of them had ␣ v ␤ 3 expression.
Integrin

Adenovirus transduction of cell lines
Bladder cancer cell lines were readily transduced with adenoviral vectors (Figure 3a and b) , while the CAR negative cell line CHO was resistant even with 15 times p.f.u./cell of vector (Figure 3c ). The T24 cells, which had the vector penton base and integrins (GRGDSP) was used ( Figure 4 ). We could partly inhibit the adenoviral transduction, but not to the same degree as using anti-CVADR antibodies. Again, cells with lower integrin expression were easier to block (T24, RT-112). Attempts to block both CVADR and integrins simultaneously only had minimal additional effects compared with blocking CVADR and integrins separately. Blocking with irrelevant control peptide did not affect transduction. Since all cell lines are
Figure 1 CVADR and integrin expression in bladder cancer. Human bladder biopsies broadly express CVADR (a-e), but the magnitude of expression varies. Tumor cells close to blood vessels were often more strongly stained while the vessels themselves remained negative for CVADR. Panels a and b exhibit an intermediate staining (++ in
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Figure 3 In vitro transduction of bladder cancer cell lines. Human bladder cancer cell lines are transducible with adenoviral vectors, as shown in (a) (J82) and (b) (T24). CHO cells, which are CVADR-negative were not transducible (c). A vector containing CD154 (Ad-CD154) or an empty control vector (Ad-dl30-7) was used. Three days after transduction, cells were stained with a PE conjugated anti-CD154 mAb and analyzed by flow cytometry. Filled curves represent Ad-dl70-3 transduced cells negative for CD154 expression, and bold lines represent Ad-CD154 transduced cells.
highly MHC class I-positive, blocking experiments with anti-MHC class I antibodies were performed. These experiments revealed that the transduction of T24 cells could be reduced by only 5-8%, whereas the other cell lines remained fully transducible after using the same amounts of antibodies (data not shown).
Discussion
Our present studies show that human bladder cancer biopsies and cell lines express CVADR, a pivotal receptor for adenovirus serotype 5 vector attachment to the cell surface. In fact, all primary biopsies (n = 27) and cell lines (n = 5) investigated in this study were positive for this receptor, although some biopsies (7/27) only showed small positive areas. The CVADR expression seems to increase in human umbilical vein endothelial cells if the cells are cultured at high density, while this did not seem to affect CVADR expression on HeLa cells. 17 The cell density in culture did not affect CVADR expression in our experiments. The question remains what mechanisms regulate CVADR expression, and whether the expression could be elevated on target cells before adenovector gene therapy.
Adenoviral transduction of tumor cell lines could be reduced with antibodies against CVADR if low numbers of vector particles were admixed with the tumor cells. Transduction of the T24 cell line with a low-grade expression of CVADR was easily blocked, while higher amounts of blocking antibodies were required to block other cell lines. CHO cells that lack CVADR expression could not be transduced even with 15 times p.f.u./cell. This indicates that CVADR is an essential receptor for adenoviral transduction of bladder cancer cells. Since integrins were earlier shown to be important for effective internalization of the vector into the cells, 7, 8 we also wanted to block this pathway for transduction. Antibodies that successfully block the biological activity of integrins are lacking, and we therefore used a peptide (GRGDSP) that blocks the interaction between the adenoviral penton base RGD sequence and integrins. 8 These studies showed minimal blocking effects, and only cell lines with a low integrin expression (T24 and RT-112) were affected using high amounts of peptide (2 mM). Simultaneous blocking of integrins and CVADR was without effect. CHO cells that are positive for integrin ␣ v ␤ 5 but negative for CVADR were not transducible, which demonstrates that integrins alone are not sufficient for transduction. In our studies, integrins did not seem to have a major role under optimized transduction conditions in vitro, although in vivo infection may be more effective in the presence of integrins.
We were unable to completely block adenoviral transduction in the majority of cell lines, and the presence of other receptors for adenoviral uptake on bladder cancer cell lines cannot be ruled out. However, the abundance of CVADR expressed on these cells prohibits complete blocking with antibodies. MHC class I molecules have been suggested as alternative attachment receptors for adenoviruses. 6 All the investigated bladder cancer cell lines in our study were highly positive for MHC-I, and blocking studies using MHC-I antibodies had slight effects on the transduction of the cell line T24, whereas other cell lines remained unaffected.
There has been a vigorous debate about the use of serotype 5 adenoviral vectors in human gene therapy, since these viruses are immunogenic and may cause an anaphylactic shock if administered in high titers directly into the blood stream of preimmune patients. 1 However, Werthman et al 18 injected adenoviral vectors both intraperitoneally (i.p.) and intravesically by instillation into the bladder in mice. This study showed that i.p. injection produced viral infection of several organs besides the targeted tumor, while intravesical instillation into the bladder infected only a few epithelial cell layers of the bladder. Thus, the bladder seems to be well isolated, and may be the ideal organ for adenoviral vector-based cancer gene therapy.
Taken together, urinary bladder cancer seems to be a tumor well suited for adenoviral vector-based gene therapy due to the abundant expression of important receptors for attachment, internalization and membrane permeabilization. However, optimal transduction strategies need to be developed that circumvent physical barriers such as mucin.
Materials and methods
Culture of human urinary bladder cell lines
The human bladder cancer cell lines J82 (kind gifts of Dr J Carlsson, Uppsala University, Sweden), T24 (gift of Dr A Richter-Dahlfors, Karolinska Institute, Sweden), RT-112 (DSMZ, Braunschweig, Germany) and (DSMZ) were cultured in RPMI supplemented with 10% fetal bovine serum (FBS), 1% glutamine, 1% penicillinstreptomycin (PEST) (Life Technologies, Paisley, UK). VM-CUB1 (DSMZ) was cultured using DMEM supplemented with 10% fetal bovine serum (FBS), 1% glutamine, 1% penicillin-streptomycin (PEST) and 0.1% sodium pyruvate (Life Technologies). 293 human kidney cells modified for production of adenoviral vectors (ATCC, Bethesda, MD, USA) and Chinese hamster ovarian (CHO) cells (ATCC) were cultured with DMEM medium as described above.
Human biopsies
Biopsies were collected during transurethral resection from patients with either superficially or invasively growing bladder carcinoma. Samples were frozen and stored at -70°C or short-time cultured (see below).
Adenoviral vectors
Replication-incompetent E1 + E3 deleted adenovirus (Ad) serotype 5 vectors containing the murine CD154 (Ad-CD154) as a marker gene were used. 15 As a negative control, the Ad-dl70-3 'empty' control vector was used (a kind gift from Dr Frank Graham, McMaster University, Hamilton, Ontario).
Adenoviral transduction
The cells were transduced by pulsing with adenoviral vectors (10-200 p.f.u./cell) for 1-2 h in serum-free cell culture medium (200 (l). After this first incubation, 2 ml ordinary medium was added and the vector pulse was continued. Cells were analyzed for CD154 transgene expression at different time-points after transduction by flow cytometry or immunocytochemistry. For blocking studies, different concentrations (1-10 g) of monoclonal antibodies against CVADR (RmcB) 19 or MHC class I (DAKO, Carpinteria, CA, USA) were incubated with 200 000 cells on ice for 40 min. Adenoviral vectors were added and the incubation was continued for 1 h at 37°C. Cells were washed with PBS and further cultured with ordinary medium. For blocking of vector-integrin interactions, 2 mM blocking peptide (GRGDSP) or control peptide (GRGESP) (Bachem, Switzerland) was used in the same manner as the antibody.
Flow cytometry CD154 cell surface expression was detected by flow cytometry (FACSCalibur, Becton Dickinson, Sunnyvale, CA, USA) using Armenian hamster anti-murine CD154 conjugated to phycoerythrin (PE) (PharMingen, San Diego, CA, USA) Single cell suspensions of 1 × 10 5 cells were incubated with antibodies for 10 min at room temperature, washed in 2 ml PBS, centrifuged at 200 g and the supernatant was decanted. Cells were resuspended in 200 (l 1% paraformaldehyde in PBS before analysis.
Immunohistochemistry
Six-micrometer sections of tumor biopsies were placed on ChemMate Capillary Gap Microscope Slides and stained with TechMate 500 Plus (DAKO). Slides were fixated with 4% paraformaldehyde and stained with the primary antibodies rabbit anti-human/mouse-CVADR antibody, 5 mouse anti-RmcB (CVADR), 19 and mouse anti-human integrin ␣ v ␤ 3 or ␣ v ␤ 5 (Chemicon International, Temecula, CA, USA) . Secondary antibodies were swine anti-rabbit Ig/rabbit APAAP or rat anti-mouse Ig/rat APAAP (DAKO). As a control of the staining irrelevant primary antibodies was used, also 293 and CHO cells were used as positive and negative controls, respectively. The tumor material was further classified for grade and stage.
RT-PCR
RNA was isolated from cell lines using the TRIzol Reagent (Life Technologies). The RNA pellet was suspended in diethyl pyrocarbonate-treated water (DEPCwater, RNAase free). The following CVADR primers were used for PCR amplification: forward 5'-CCTGCGA GATGTTACGTTGA and reverse 5'-CGCACCCAT TCGACTTAGAT. For detection of ␤-actin the following primers were used: forward 5'-GAGCAAGAGAGGCAT CCTCA and reverse 5'-AGACAGCACTGTGTTGGCGT. All primers were purchased from Cybergene, Stockholm, Sweden. The PCR reaction was performed for 35 cycles at 94°C for 45 s, 55°C for 45 s, 72°C for 1 min followed by extension at 72°C for 10 min. PCR reactions were carried out in the presence of 5 mM each of dATP, dCTP, dGTP and dTTP, 1.5 mM MgCl, 25 pg/mol of primer, PCR buffer and 1 unit of Taq polymerase (Life Technologies) in a total volume of 50 l. PCR products were analyzed on a 1% agarose-gel containing ethidium bromide.
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